← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2000Last known activity
Mar 31, 2023
Timeline
1920s
- Jan 1, 1924
Bial— Founded
Drugs by trial phase (34 distinct, 134 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
- Cardiovascular Diseases
- Diabetic Neuropathies
- Disease
- Epilepsies, Partial
- Epilepsy
- Familial Primary Pulmonary Hypertension
- Fibromyalgia
- Heart Failure
- Hypertension
- Migraine Disorders
- Myofascial Pain Syndromes
- Neuralgia
- Neuralgia, Postherpetic
- Pain
- Parkinson Disease
- Peripheral Nervous System Diseases
- Recurrence
- Seizures
Recent trials (50)
- NCT05819359Lead sponsorPhase 2Mar 31, 2023
- NCT05819359Study directorPhase 2Mar 31, 2023
- NCT04990284Lead sponsorPhase 4Nov 30, 2021
- NCT05220072Lead sponsorPhase 1Aug 28, 2021
- NCT04986995Lead sponsorPhase 4Jun 9, 2021
- NCT04978597Lead sponsorPhase 3May 31, 2021
- NCT04986982Lead sponsorPhase 4Feb 25, 2021
- NCT06009185Lead sponsorPhase 2Jun 26, 2019
- NCT04316143Lead sponsorPhase 2Jun 6, 2019
- NCT06597084Lead sponsorPhase 2May 29, 2019
- NCT04069130Lead sponsorPhase 1Apr 8, 2019
- NCT03820037Lead sponsorPhase 1Mar 31, 2019
- NCT03708146Lead sponsorPhase 1Jun 24, 2018
- NCT07173738Lead sponsorPhase 1Jun 11, 2018
- NCT03489005Lead sponsorPhase 1Apr 30, 2018
Details
- Founded
- Trofa, PT Jan 1, 1924
- Last known activity
- Mar 31, 2023